COVID-19 Online Newsroom

IdentifySensors Biologics, a Purdue University-affiliated technology firm developing a rapid diagnostic platform for detecting pathogens, including SARS-CoV-2, has entered into a new partnership with Purdue Research Foundation and will open an office in Purdue's Discovery Park District.

Artist Suzanne Brennan Firstenberg, with help from the George Washington University and University of Maryland, has launched a digital version of her public art exhibition "IN AMERICA How Could This Happen..." in an effort to continue honoring those who have died and the deaths yet to come.

Frontline staff at Norfolk and Norwich University Hospitals (NNUH) are among the first in the country to benefit from the rollout of more accurate saliva tests in a bid to curb Covid transmission rates. Combined with the vaccination programme, these rapid tests should help to significantly reduce the ability of the virus to spread in healthcare settings.

Utilizing an automated system and whole genome sequencing, a team of scientists from West Virginia University and Marshall University is set to analyze hundreds of samples per week to identify COVID-19 variants from across West Virginia.

The Altimmune Inc. vaccine candidate that was tested preclinically at the University of Alabama at Birmingham last year is expected to start patient enrollment for its Phase 1 clinical trial next week.

At the start of the COVID-19 pandemic, we switched up our usual content to bring viewers reliable coronavirus info from the experts. One year later, we're checking back in with some of those experts and asking, 'what do we know now that we didn't back then?': https://youtu.be/41l4DBdK7Bw.

The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute's eRapid technology with the company's proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications.

In an effort to help schools reduce the risk of COVID-19 outbreaks as they resume in-person instruction, UC San Diego and the County of San Diego are testing the Safer at School Early Alert system to detect SARS-CoV-2 at schools and child care centers.